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Summary
This study aimed to evaluate the accuracy of magnetic resonance imaging (MRI) in the detection of deep myometrial
invasion and cervical extension by endometrial carcinoma. This prospective study included 101 patients with histologically
documented endometrial carcinoma, between July 1998 and April 2004. The findings of preoperative pelvic MRI were
compared with histological diagnosis. From 101 cases studied by pelvic MRI, 43 were classified as deep myometrial invasion
(50% of myometrium), where the pathological evaluation confirmed as having deep myometrial invasion. Cervical
extension in the MRI study was found in 19 cases. Pathologic study found cervical extension and/or invasion in 31 cases
including all cases identified by MRI. The accuracy, sensitivity and specificity of MRI were 95%, 89%, 100%, detecting deep
myometrial invasion and 88%, 61%, 100%, detecting cervical invasion, respectively. The high accuracy achieved makes MRI
an adequate method for determine the depth of myometrial and cervical invasion in endometrial carcinoma.
Introduction
In Portugal, endometrial carcinoma is the second most
common cancer of female genital tract (Cunha et al. 2001).
Presenting as abnormal vaginal bleeding, the disease
occurs most frequently in white women, with peak
incidence between ages 55 and 65. Known risk factors are
unopposed oestrogen intake, tamoxifen, nulliparity, obesity,
diabetes and the Stein – Leventhal syndrome (Belloni et al.
1990).
In 1988, the International Federation of Gynecology and
Obstetrics (FIGO) adopted a surgico-pathological system
for the staging of endometrial carcinoma (Anonymous
1989). The rationale behind the change from a clinical to a
surgico-pathological staging system was based on the
inaccuracy of clinical staging and subsequent limitations of
treatment planning (Frei et al. 2000).
Treatment and prognosis depend on several factors,
including stage, tumour grade, depth of myometrial pene-
tration, cervical penetration and nodal metastasis (Manfredi
et al. 2004; Kinkel et al. 1999; Hricak et al. 1991; Sironi
et al. 1992a).
Symptomatic abnormal bleeding occurs in about 80%
of patients, and most of the cases are diagnosed in
an early-stage (Sironi et al. 1992a), and cured (Lien et al.
1991).
Because extrauterine disease and lymph node metastases
strongly correlates with the depth of myometrial invasion
and histological tumour grade (Belloni et al. 1990), pre-
operative knowledge of myometrial invasion directly influ-
ences the choice of treatment (Kinkel et al. 1999).
Patients with grade 3 carcinomas have a high prevalence
of lymph node metastases and should be proposed to
undergo surgical lymph node assessment (Frei and Kinkel
2001). In most institutions, patients with 450% of myo-
metrial invasion are also considered for further surgical
staging, including pelvic and para-aortic lymphadenectomy.
Therefore, treatment should include intraoperative staging
by a pathologist and a gynaecologist with special training in
oncological surgery (Frei and Kinkel 2001). Recent data
from the ASTEC study, presented at the 37th Annual
Meeting of the Society of Gynecologic Oncologists of North
America in March 2006, has shown preliminary data that
surgical staging by way of pelvic and para-aortic lymphade-
nectomy does not improve survival (Kitchener 2006). The
knowledge of cervical invasion may alter the type of hyste-
rectomy that is performed and the detection of parametrial
invasion should raise the possibility of radiation therapy as
the first treatment (Kinkel et al. 1999).
Pelvic MRI is an examination accepted in the character-
isation of pelvic tumours due to its multiplanar capacity and
its excellent resolution of soft tissue contrast (Cunha et al.
2001; Sironi et al. 1992a; Sironi et al. 1992b). High accuracy
in the assessment of the depth of myometrial infiltration
(superficial/deep) as well as the extent of cervical invasion
and identification of enlarged pelvic and para-aortic lymph
nodes has been described in the literature (Cunha et al.
2001; Manfredi et al. 2004).
In this prospective study, we evaluate the accuracy of MRI
in endometrial carcinoma (invasion of the deep myome-
trium and of the uterine cervix), compared with surgico-
pathological findings.
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Material and methods
Between July 1998 and April 2004, a total of 108 con-
secutive patients with endometrial carcinoma treated in the
Department of Gynaecology of the Portuguese Institute of
Oncology, were considered for inclusion in this prospective
study. In this series, 40 cases were previously reported in
the literature (Cunha et al. 2001).
Inclusion criteria were the presence of endometrial
carcinoma histologically documented by biopsy and con-
firmed on the surgical specimen and a preoperative
pelvic MRI.
One patient was excluded from the study because she
subsequently underwent surgery at a different institution.
Six patients were also excluded because they did not
undergo surgery – four were referred to radiation therapy
and the other two were treated with hormonal therapy.
Therefore, our study included 101 patients with an
age range between 48 and 89 years (mean¼ 68.5 years).
A total of 11 were premenopausal (11%) and 90 were
postmenopausal (89%); regarding exogenous hormonal
therapy, three were on contraceptives, eight were recei-
ving hormonal replacement therapy and three were
taking tamoxifen for breast cancer. The average
time between MRI and hysterectomy was 45 days (range
0 – 90 days).
All patients were submitted to abdominal hysterectomy
and bilateral salpingo-oophorectomy, with pelvic lympha-
denectomy in 36, and selective para-aortic lymphadenect-
omy in 15.
The histological diagnosis and the tumour grade are
shown in Table I. At histological examination, 86 were
endometrioid adenocarcinomas, five were papillary serous
adenocarcinomas, three were clear cell carcinomas, three
were mucinous adenocarcinomas, one was a mixed mali-
gnant Mu¨llerian tumour, one was a glassy cell carcinoma
and two were undifferentiated carcinomas. In regard to
tumour grade, 39 patients had grade 1 tumours, 34 had
grade 2 tumours and 28 had grade 3 tumours. The FIGO
stages were as follows: 7 stage IA (7%), 40 stage IB (39%),
20 stage IC (20%), 19 stage II (18%), 11 stage III (10%)
and 4 stage IV (4%).
MRI studies were performed with a 1.0-Tesla super-
conducting magnet (model Gyroscan NT; Philips Medical
Systems, Einthoven, Netherlands), using a body coil.
In each examination, axial T1-weighted (TR/TE¼ 550/
14 ms) and axial and sagittal T2-weighted (TR/TE¼ 4090/
150 ms) images were acquired. The parameters were two
acquisitions, a matrix of 2566256, with 5 mm slice thick-
ness and 1 mm interslice gap.
Dynamic study after rapid manual intravenous admin-
istration of 0.1 mmol/kg gadopentetate dimeglumine
(Magnevist; Schering, Berlin, Germany) was performed
using a fast field-echo pulse sequence, with multisection in
the sagittal plane of the uterine corpus. The parameters
were 16/5.3 ms (TR/TE), a flip angle of 258, a 2566256
matrix and an acquisition of images at equilibrium phase,
90 – 120 s after the injection of the contrast material.
MR images were independently analysed prospectively
by two radiologists (C.V., T.M.C.) prior to surgery.
Interpretation discrepancies were resolved by consensus.
The images were interpreted for the following parameters:
depth of myometrial invasion, cervical invasion and lymph
node enlargement.
Myometrial infiltration was classified in superficial
(550% of the thickness of the myometrium) if there was
disruption or discontinuity of the junctional zone in the
T2-weighted images or when the internal surface of the
myometrium was irregular in the dynamic study (Figure 1),
and in deep invasion (50% of the thickness of myome-
trium) when the tumour was observed reaching the
external half of the myometrium (Figures 2 and 3). Regular
thinning of the myometrium was classified as superficial
invasion (Figure 4).
Cervical extension was determined when widening of the
internal os and cervical canal and/or as abnormal signal
intensity in the cervical canal; cervical epithelium disap-
peared partly or totally and/or disruption of the normal low
signal intensity of junctional zone in the cervix on sagittal
T2-weighted images was visualised. In the dynamic study,
the cervical infiltration was considered when interruption
of the contrast enhancement of the epithelium (Figure 5) or
the cervical stroma (Figure 6) was observed.
MRI findings were compared with surgico-pathological
results, and the diagnostic accuracy, sensitivity, speci-
ficity, positive and negative predictive values were cal-
culated for myometrial infiltration and cervical invasion
by endometrial carcinoma [sensitivity¼TP/(TPþFN),
specificity¼TN/(TNþFP) and accuracy¼ (TPþTN)/
(TPþTNþFPþFN)], where TP is the true positive,
TN is the true negative, FN is the false negative and
FP is the false positive (Glantz 1981; Landis and Koch
1997).
Results
In our 101 cases studied, according to surgico-pathological
data, 50% of myometrial infiltration was found in 48
cases, 11 had cervical extension to the epithelium and 20
had stromal invasion. MRI correctly assessed 43 (90%)
patients with deep myometrial invasion and underesti-
mated five cases (10%). Among the five understaged cases,
one had an 80-day interval between MRI and the surgery
and another was a grade 3 neoplasm. In two others cases,
the evaluation was difficult, by the presence of an
intramural leiomyoma and by the polypoid growth of the
tumour. In the last case, invasion of the external half of the
myometrium consisted of penetration by small isolated
glandular foci.
Overall, MRI sensitivity, specificity, diagnostic accuracy
and positive and negative predictive values for deep myo-
metrial invasion was 89%, 100%, 95% and 100%, 91%,
respectively.
Regarding cervical extension, MRI found invasion in
19 (61%) cases. Histopathological study detected cervical
Table I. Endometrioid carcinoma: histological type and grade
Tumour grade
Histopathological type 1 2 3 Total
Endometrioid adenocarcinoma 36 34 16 86
Mucinous adenocarcinoma 3 3
Papillary serous adenocarcinoma 5 5
Clear cell carcinoma 3 3
Undifferentiated carcinoma 2 2
Mixed malignant Mu¨llerian tumour 1 1
Glassy cell carcinoma 1 1
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Figure 1. Images of a 55-year-old woman with superficial myometrial invasion. (A) Axial T2-weighted image (left) shows an expanded
central zone of high signal intensity with irregularity of the junctional zone, indicating invasion of550% of the thickness of the myometrium.
On the sagittal dynamic MR image, after contrast enhancement (right) the demonstration of the internal surface myometrial invasion is better
observed than on the T2-weighted image by the irregular interface between the tumour and the myometrium (arrow). (B) Gross specimen of
hysterectomy with bilateral salpingo-oophorectomy and sagittal section of the uterus, with a polypoid mass invading the superficial
myometrium (arrow). An intramural leiomioma in the uterine corpus is also documented.
Figure 2. A 62-year-old woman with deep myometrial invasion. (A) Sagittal T2-weighted image (left) and sagittal dynamic gadolinium
enhanced images (centre and right). The demonstration of the tumour extending into the outer half of the myometrium (deep myometrial
invasion) is better identified in T1-weighted images after contrast (arrows) due to the presence of adenomyosis documented in the
T2-weighted image. (B) Gross specimen of hysterectomy with bilateral salpingo-oophorectomy and sagittal section of the uterus with a
polypoid tumour occupying the endometrial cavity and invading the deep myometrium. (C) Histological section of the uterine wall with an
adenocarcinoma invading the external half of the myometrium (arrow).
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extension and/or invasion in 31 cases, including all cases
identified by MRI. In the 12 patients understaged by
MRI, six cases had only endocervical epithelial extension
(stage IIA).
The general sensitivity, specificity, diagnostic accuracy,
and positive and negative predictive values for cervical
invasion was respectively: 61%, 100%, 88% and 100%,
85%, respectively.
Figure 3. Histological stage I endometrial carcinoma with invasion of the outer half of the myometrium. (A) Sagittal T2-weighted image and
(B) sagittal dynamic MR images after contrast. The uterus is mostly occupied by the tumour with irregular thinning of the myometrium
(arrows) caused by deep myometrial invasion.
Figure 4. Endometrial carcinoma with superficial myometrial invasion in an 83-year-old woman. (A) Sagittal T2-weighted image (left) shows
tumour causing segmental disruption of the junctional zone with tumour confined to the inner half of the myometrium; and sagittal dynamic
enhanced image (right) shows a regular thinning of the myometrium (arrow). (B) Histological section of the uterine wall with an
adenocarcinoma invading the internal half of the myometrium.
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Discussion
Endometrial carcinoma is the second most common female
genital tract carcinoma. Treatment planning and prognosis
are determined by prognostic factors that include depth of
myometrial invasion, cervical extension and lymph node
metastases (Frei and Kinkel 2001). A higher tumour grade
correlates with lower survival rates and higher rate of
myometrial invasion (Kinkel et al. 1999). The tumour
grade and the depth of myometrial invasion correlate
strongly with the prevalence of lymph node metastases
(Frei and Kinkel 2001). As clinical staging carries an
overall understaging rate of 13 – 22%, routine surgical
staging has been recommended by FIGO since 1988 (Frei
and Kinkel 2001; Kinkel et al. 1999).
Surgery is the treatment of choice in patients with non-
invasive or locally advanced disease (Manfredi et al. 2004).
Patients with 450% myometrial invasion have a six- to
seven-fold higher prevalence of pelvic and para-aortic
lymph node metastases and of advanced surgical stage
(Frei et al. 2000). Therefore, patients with deep myome-
trial invasion have been considered for more aggressive
surgical staging, which includes pelvic and para-aortic
lymphadenectomy (Frei et al. 2000). Recent data from a
Study in the Treatment of Endometrial Cancer (ASTEC)
has shown that lymphadenectomy in addition to hyster-
ectomy and salpingo-oophorectomy does not improve
survival in early-stage endometrial carcinoma. This study
was designed to assess the effect of lymphadenectomy and
adjuvant external beam radiation therapy in the treatment
of endometrial cancer (Kitchener 2006).
As well-established ‘primary treatment in a cancer
patient gives the best opportunity for cure’ (Kinkel et al.
1999), accurate preoperative assessment of the depth of
myometrial invasion and/or cervical invasion is very
important in treatment planning (Cunha et al. 2001).
Among the imaging modalities that have been proposed
for the evaluation of myometrial invasion, contrast-
enhanced MRI has a substantially higher sensitivity and
specificity than endovaginal US and CT (Frei et al. 2000).
MRI studies allow tumour visualisation, determine the
degree of myometrial invasion, and also evaluate cervical
extension, obtaining good accuracy in endometrial tumour
evaluation.
The presence and depth of myometrial infiltration can be
assessed on T2-weighted images as an interruption of the
Figure 5. Images obtained in a 53-year-old woman with endocervical glandular invasion. (A) Sagittal T2-weighted image and (B) sagittal
dynamic gadolinium enhanced image show the tumour in the uterine cavity with superficial myometrium invasion. Adenomyosis of the
anterior wall of the uterus (arrow) is identified on T2-weighted image. We can also see the tumour extending into the cervical canal and
marked widening of the internal os. A regular interface between the tumour and the cervical stroma is well documented in sagittal dynamic
gadolinium enhanced image.
Figure 6. Grade 2 endometrial adenocarcinoma with deep myometrial invasion and cervical extension in a 51-year-old woman. (A) Sagittal
T2-weighted image (left) and sagittal dynamic gadolinium enhanced image. The images demonstrated the tumour extending into the outer
half of the myometrium (black arrows) and into the cervix. There is widening of the internal os and of the cervical canal with deep invasion of
cervical stroma (white arrow). Differentiation of tumour from residual myometrium is easy to detect in the dynamic MR image. (B) Sagittal
section of hysterectomy gross specimen with the tumour invading deep wall of the myometrium and with cervical stromal invasion.
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junctional zone, which appears with low signal intensity.
However, in postmenopausal women, this could be more
difficult to assess because uterine involution makes the
junctional zone poorly visible and the myometrium thinner.
To overcome this limitation, a dynamic study should be
performed, because it can depict different enhancement
times of the adenocarcinoma compared with those of the
adjacent myometrium, improving the contrast resolution of
the tumour and myometrium.
In this MRI study, we used both T2-weighted images
and a dynamic study to evaluate the depth of myometrial
invasion and cervical extension. The dynamic study was
extremely helpful in those cases where the junctional zone
was not clearly visualised.
Our results are in keeping with previous series (Hardesty
et al. 2000; Yamashita et al. 1993; Ito et al. 1994). We
obtained an accuracy of 95% in the evaluation of deep
myometrial invasion and an accuracy of 88% regarding
cervical extension. The high diagnostic accuracy in the
assessment of deep myometrial infiltration in our series was
improved because we acquired images during the equili-
brium phase of the dynamic study, i.e. 90 – 120 s after
contrast administration, according to Manfredi et al.
(2004). In their study, the lesion detection was more easily
achieved during the equilibrium phase, where a signifi-
cantly better tumour and myometrium contrast-to-noise
ratio is present than in the other phases of the dynamic
study.
The presence of leiomyomas, high-grade tumour pro-
gression and the presence of small isolated tumoural foci
were factors that in our opinion decreased the accuracy in
our study as previously described.
In conclusion, the high accuracy achieved in this
study suggests that MRI should be considered as a method
for preoperative endometrial carcinoma ‘radiological
staging’.
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